API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
EU WC
0
Listed Suppliers
0
0
USA (Orange Book)
Europe
0
Canada
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-fostamatinib-disodium-1655270191.pdf
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-aprepitant-azilsartan-bupivacaine-cladribine-elrombopag-fosnetupitant-fostamatinib-ivacaftor-and-sodium-thiosulfate-1655270821.pdf
https://www.prnewswire.com/news-releases/fostamatinib-selected-for-nih-activ-4-covid-19-clinical-trial-301321604.html
https://www.clinicaltrialsarena.com/news/rigel-fostamatinib-primary-endpoint/
https://www.rigel.com/investors/news-events/press-releases/detail/312/positive-topline-data-shows-fostamatinib-meets-primary
https://www.clinicaltrialsarena.com/news/rigel-concludes-enrolment-trial/
https://www.prnewswire.com/news-releases/rigel-and-medison-announce-health-canada-approval-of-tavalisse-an-oral-medication-for-the-treatment-of-adults-with-chronic-immune-thrombocytopenia-301178615.html
https://www.biospace.com/article/releases/rigel-announces-nih-nhlbi-sponsored-trial-of-fostamatinib-in-hospitalized-covid-19-patients-in-collaboration-with-inova/
https://www.prnewswire.com/news-releases/rigel-announces-conference-call-and-webcast-to-report-second-quarter-2020-financial-results-and-business-update-301100724.html
https://www.prnewswire.com/news-releases/rigel-announces-availability-of-tavlesse-fostamatinib-disodium-hexahydrate-in-europe-301090877.html
https://www.prnewswire.com/news-releases/rigel-announces-availability-of-tavlesse-fostamatinib-disodium-hexahydrate-in-europe-301090877.html
https://www.prnewswire.com/news-releases/rigel-to-present-poster-highlighting-tavalisse-at-the-virtual-edition-of-the-25th-european-hematology-association-eha-annual-congress-301074137.html
https://www.prnewswire.com/news-releases/rigel-to-present-at-the-jefferies-virtual-healthcare-conference-301064907.html
https://www.prnewswire.com/news-releases/rigel-receives-positive-trend-vote-from-chmp-for-fostamatinib-disodium-hexahydrate-for-adult-patients-with-chronic-immune-thrombocytopenia-itp-in-europe-300941069.html
https://www.biopharmadive.com/news/sobi-acquires-dova-doptelet-rare-disease-hematology/564004/
https://www.prnewswire.com/news-releases/rigel-pharmaceuticals-enters-collaboration-and-license-agreement-with-kissei-pharmaceutical-co-ltd-to-develop-and-commercialize-tavalisse-fostamatinib-disodium-hexahydrate-in-japan-and-other-asian-countries-300739148.html
https://www.prnewswire.com/news-releases/rigel-receives-ema-validation-of-the-marketing-authorization-application-for-fostamatinib-disodium-hexahydrate-in-chronic-immune-thrombocytopenia-itp-in-adult-patients-300729202.html